&#xa0;

[[[Written evidence submitted by ]]]

[[[National Institute of Biological Standards and Control ]]]

[[[(BTO00005)]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;December 2013&#xa0;Attachments&#xa0;&#xa0;Dr Philip Minor (NIBSC,MHRA)Professor Noel Gill (PHE) Dr Jillian Cooper (NIBSC, MHRA)Professor Jean Manson (Roslin Institute)Professor Richard Knight (CJDRSU)Dr Simon Mead (MRC Prion Unit)Dr Neil Almond (NIBSC, MHRA) Dr David Anstee (NHSBT)Professor Robert Will (CJDRSU)Dr Maurice Bardsley (VLA) Dr Jim Hope (VLA)Professor Christine Lee (Royal Free Hospital, retired)Gill Turner (CJD Support Network)Professor Marc Turner (NHSBT) Professor Janet Darbyshire (MRC, retired)Dr Micha Nuebling (Paul Ehrlich Institute, Germany)Dr Joliette Coste (French Blood Transfusion Service)Dr Stephen Lee (MHRA)Dr Nick Andrews (PHE)Mark Noterman (DH)Dr Gary Mallinson (NHSBT)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Cooper, J.K., Andrews, N., Ladhani, K., Bujaki, E., &amp; Minor, P.D.. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease. Vox Sanguinis 2013, 105, (3) 196-204;   Cooper, J.K., K. Ladhani, and P. Minor, Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sanguinis, 2012. 

[[[102]]](2): p. 100-9;  J. K. Cooper, K. Ladhani &amp; P. D. Minor Reference materials for the evaluation of pre-mortem variant Creutzfeldt–Jakob disease diagnostic assays Vox Sanguinis (2007) 

[[[92]]], 302–310

[[[&#xa0;]]]&#xa0;The aim of the CJD resource centre and its oversight committee is to ensure fair and appropriate access to extremely rare blood components from clinical cases of vCJD.  Samples used in these studies were generated by NIBSC in collaboration with other TSE research groups who supplied animal samples (AHVLA and Roslin); the CJD Surveillance unit and the MRC Prion clinic who provided CJD samples and the UK National Blood and Transfusion Service who provided normal donor samples.  Both test sensitivity (how little infectious material can be detected) and specificity (number of samples incorrectly scored positive) studies were performed.  Completed evaluation studies:Company ASamples  provided:&#xa0;Spiked panel sets (vCJD tissue homogenates in pooled human plasma              200648 samples)Sheep plasma samples (Scrapie, BSE infected and Control; total 250)              2008UK blood donor plasma (1000 individuals, unfrozen, prepared                             2008daily at NIBSC)                                                        Primate plasma (BSE infected and controls; total 60)                                          2009UK donor plasma (Frozen set, 1000 individuals)                                                        2009Variant and Sporadic CJD plasma (3 variant, 2 sporadic)              along                            2009With normal donor samples (500)                             &#xa0;Complete evaluation was published in 2013:&#xa0;Cooper, J.K., et al., Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease. Vox Sang, 2013. 

[[[105]]](3): p. 196-204.&#xa0;Company B&#xa0;&#xa0;Spiked panel sets (vCJD tissue homogenates in pooled human plasma,               200948 samples)              Sheep plasma samples (Scrapie, BSE infected and Control; total 250)              2009UK donor plasma (2000 samples, unfrozen (1000); frozen (1000)                            2011Variant CJD plasma (2 samples)              plus 200 normal US donor plasma               2012samples                                                                      &#xa0;Other tests evaluated (research and commercial) 9 groups provided with detergent-extracted plasma (48 samples)              200412 groups provided with spiked plasma panel (cryo-depleted                            2006/2007 pooled plasma, 48 samples)                                                        6 groups provided with spiked panel set using pooled whole plasma              2007/8/9/10&#xa0;Following evaluation of the blinded sample sets, problems with sensitivity, specificity and reproducibility were identified.  Results for these studies were published in 2012 in:&#xa0;Cooper, J.K., K. Ladhani, and P. Minor, Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sang, 2012. 

[[[102]]](2): p. 100-9.&#xa0;Research groups (X5) all still currently activeSpiked panel sets (vCJD tissue homogenates in pooled human plasma, total samples 24)               2011/12Sheep buffy coat preparations (scrapie and control, 12 samples sent) to                                          2013&#xa0;Commercial developers (X1)Spiked panel sets (vCJD tissue homogenates in human pooled plasma, total samples 24)              2013

[[[&#xa0;]]]&#xa0;&#xa0;